뉴스/소식

As June brings summer in full swing, GR Korea brings you timely updates on Korea’s dynamic biopharma industry. Included in this issue are updates on new state subsidies for healthcare technology and vaccine R&D, notable drug approvals under a new tes...

The 22nd National Assembly began three weeks ago, but the two major parties have been in major conflicts right from the start over the formation of standing committees, giving a preview for a bumpy parliamentary and political landscape in the years a...

With the 22nd National Assembly commencing two days ago, the People Power Party and the Democratic Party have finalized their preparations by reviewing legislative agendas and interparty strategies during their orientation workshops.This appendix, su...

In May, GR Korea continues to share important and noteworthy news from the healthcare sector. Particularly, with the 22nd National Assembly (NA) officially beginning its term on 30 May, the healthcare sector should pay close attention to developments...

This week, Korea's 22nd National Assembly (NA) officially kicks off its four-year journey.  As the two major political parties—the minority ruling People Power Party and the majority opposition Democratic Party—finalize their internal strategies, the...

This month, GR Korea continues to share important and noteworthy news from the healthcare sector. In April, the 22nd General Election took a place, and both the ruling and opposition parties met in agreement on bio industry-related pledges, such as i...